Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy

Fig. 3

The boxplot with scatter points is used to illustrate the percentage of CD4⁺CD25⁺CD127lowTregs across different subgroups of HCC patients. (A): Recurrence within 6 months. (B): Recurrence within 12 months. (C): Recurrence within 24 months. (D): Recurrence within overall follow-up time. (E): Status within overall follow-up time

Abbreviations: Treg, regulatory T cells; HCC, Hepatocellular carcinoma

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us